Lam Research (NASDAQ:LRCX) Price Target Raised to $158.00

Lam Research (NASDAQ:LRCX) had its price target hoisted by Morgan Stanley from $137.00 to $158.00 in a research report report published on Tuesday, Marketbeat Ratings reports. Morgan Stanley currently has an equal weight rating on the semiconductor company’s stock.

Other research analysts have also recently issued reports about the stock. Dbs Bank raised their price objective on shares of Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. Wall Street Zen downgraded Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Stifel Nicolaus set a $160.00 price objective on Lam Research and gave the stock a “buy” rating in a report on Thursday, October 23rd. Mizuho lifted their price objective on Lam Research from $162.00 to $170.00 and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Finally, Rothschild & Co Redburn boosted their target price on Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Twenty-six research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $152.87.

Lam Research Stock Performance

NASDAQ:LRCX opened at $157.09 on Tuesday. The firm’s fifty day simple moving average is $149.41 and its 200-day simple moving average is $116.60. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The stock has a market cap of $197.31 billion, a PE ratio of 34.60, a price-to-earnings-growth ratio of 1.64 and a beta of 1.77. Lam Research has a fifty-two week low of $56.32 and a fifty-two week high of $167.15.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period last year, the company posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts expect that Lam Research will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.7%. Lam Research’s payout ratio is presently 22.91%.

Insider Buying and Selling at Lam Research

In other Lam Research news, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the transaction, the insider owned 56,786 shares of the company’s stock, valued at $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 102,608 shares of company stock valued at $14,916,496. Corporate insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Lam Research

Several large investors have recently made changes to their positions in LRCX. Vanguard Group Inc. grew its holdings in Lam Research by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 130,974,214 shares of the semiconductor company’s stock worth $17,537,447,000 after buying an additional 364,949 shares in the last quarter. State Street Corp boosted its position in Lam Research by 0.4% during the 3rd quarter. State Street Corp now owns 59,817,352 shares of the semiconductor company’s stock worth $8,024,684,000 after acquiring an additional 265,805 shares during the period. JPMorgan Chase & Co. boosted its position in Lam Research by 14.4% during the 2nd quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock worth $3,954,188,000 after acquiring an additional 5,102,589 shares during the period. Geode Capital Management LLC grew its stake in shares of Lam Research by 3.5% in the second quarter. Geode Capital Management LLC now owns 33,802,736 shares of the semiconductor company’s stock worth $3,280,484,000 after purchasing an additional 1,135,405 shares in the last quarter. Finally, Invesco Ltd. grew its stake in shares of Lam Research by 18.2% in the third quarter. Invesco Ltd. now owns 21,182,948 shares of the semiconductor company’s stock worth $2,836,397,000 after purchasing an additional 3,263,658 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.